As of 2024-12-11, the Intrinsic Value of Athira Pharma Inc (ATHA) is
-14.21 USD. This Athira valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.62 USD, the upside of Athira Pharma Inc is
-2,385.52%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-14.21 USD
Intrinsic Value
Athira Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-14.21 - -14.21 |
-14.21 |
-2,385.52% |
| P/E |
(43.08) - (68.59) |
(68.33) |
-11093.4% |
| DDM - Stable |
(21.23) - (61.20) |
(41.22) |
-6730.8% |
| DDM - Multi |
(21.08) - (47.79) |
(29.32) |
-4816.1% |
Athira Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
23.89 |
| Beta |
3.12 |
| Outstanding shares (mil) |
38.44 |
| Enterprise Value (mil) |
-44.96 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.77% |
| Cost of Debt |
5.00% |
| WACC |
7.22% |